From: Altered expression of ACOX2 in non-small cell lung cancer
 | Variable | LUAD | LUSC | ||
---|---|---|---|---|---|
R | p-value | R | p-value | ||
DNA Damage Response (DDR) Pathway | BRCA1 |  − 0.15 | 3 × 10–4 *** |  − 0.42 | 3.5 × 10–24 *** |
ATM | 0.03 | 0.49 | 0.12 | 0.0068 ** | |
ATR | 0.16 | 0.00023 *** |  − 0.25 | 4.3 × 10–9 *** | |
CDK1 |  − 0.24 | 2.2 × 10–08 *** |  − 0.38 | 5.7 × 10–20 *** | |
CHEK1 |  − 0.2 | 2.5 × 10–06 *** |  − 0.35 | 6.6 × 10–17 *** | |
CHEK2 |  − 0.047 | 0.27 |  − 0.47 | 6.7 × 10–31 *** | |
TP53 | 0.18 | 3.7 × 10–05 *** |  − 0.096 | 0.027 * | |
Combined Signature |  − 0.1 | 0.02 * |  − 0.37 | 3.2 × 10–21 *** | |
Mismatch excision repair (MMR) related genes | PMS2 | 0.091 | 0.034 * |  − 0.29 | 1.3 × 10–11 *** |
MLH1 | 0.22 | 2.4 × 10–07 *** | 0.21 | 1.3 × 10–06 *** | |
MSH2 |  − 0.051 | 0.24 |  − 0.36 | 1.7 × 10–17 *** | |
MSH3 | 0.099 | 0.021 * |  − 0.02 | 0.65 | |
MSH6 |  − 0.035 | 0.42 |  − 0.44 | 4.8 × 10–27 *** | |
PCNA |  − 0.19 | 5.6 × 10–06 *** |  − 0.43 | 4.7 × 10–26 *** | |
Combined Signature | 0.0013 | 0.98 |  − 0.37 | 3.2 × 10–19 *** |